Get the latest Science News and Discoveries

Low-cost MS treatment shown to be as effective as standard therapy in landmark NEJM trial - EurekAlert!


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of NEJM

NEJM

Photo of standard therapy

standard therapy

Photo of cost MS treatment

cost MS treatment

Related news:

News photo

NEJM/ASCO: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma in landmark international trial - EurekAlert!

News photo

NEJM Group launches NEJM Clinician - EurekAlert!

News photo

Novel agent ianalumab added to standard therapy extends time to treatment failure in patients with previously treated immune thrombocytopenia - EurekAlert!